|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
1996-6-5
|
|
pubmed:abstractText |
Controlled clinical trials have shown that beta-blockers can produce hemodynamic and symptomatic improvement in chronic heart failure, but the effect of these drugs on survival has not been determined.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
23
|
|
pubmed:volume |
334
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1349-55
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8614419-Adrenergic alpha-Antagonists,
pubmed-meshheading:8614419-Adrenergic beta-Antagonists,
pubmed-meshheading:8614419-Carbazoles,
pubmed-meshheading:8614419-Cardiovascular Diseases,
pubmed-meshheading:8614419-Chronic Disease,
pubmed-meshheading:8614419-Disease-Free Survival,
pubmed-meshheading:8614419-Double-Blind Method,
pubmed-meshheading:8614419-Female,
pubmed-meshheading:8614419-Free Radical Scavengers,
pubmed-meshheading:8614419-Heart Failure,
pubmed-meshheading:8614419-Hospitalization,
pubmed-meshheading:8614419-Humans,
pubmed-meshheading:8614419-Male,
pubmed-meshheading:8614419-Middle Aged,
pubmed-meshheading:8614419-Propanolamines,
pubmed-meshheading:8614419-Risk
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
|
|
pubmed:affiliation |
Division of Circulatory Physiology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
